Authors
Latest:
3 Takeaways About Managing the Cost of MSMultiple sclerosis is dependably among the most expensive chronic diseases to treat, but there are ways to reduce the size of the bill.
Latest:
Four Reasons Payers Are Investing in Real-Time Benefit CheckWhy the top PBMs are so excited about the promise of a new standardized transaction.
Latest:
Ten Things Health Execs Should Know about LymphomaNew treatment approaches could lead to even higher costs associated with lymphoma. However, experts say these treatments hold great promise and could reduce costs in the long-term.
Latest:
Seven Things Managed Care Can Learn from Other IndustriesThinking out of the box leads to the best innovation sometimes. Here are lessons healthcare leaders say can be learned from other industries.
Latest:
Opinion: Top Trends Influencing the Future of Affordable Cancer CareHere’s how community oncologists seize opportunities to improve the quality of care and create performance metrics.
Latest:
The State of Biosimilars in 2019While still largely a new phenomenon, biosimilars are here to stay-and this year will only bring more of them to market.
Latest:
Pfizer Tornado Plant Damage Not Affecting Penicillin SupplyThe supply of fentanyl, epinephrine injection, and heparin, however, have been impacted by the July 19 tornado at Pfizer's North Carolina facility.
